Ferreira, S., Chebli, J. M. F., Parra, R., Sassaki, L. Y. [., Mello, M. K. d., Luporini, R. L., . . . Troncon, L. E. D. A. (2024). Clinical Effectiveness and Safety of Vedolizumab vs. Infliximab in Biologic-Naive Ulcerative Colitis Patients: A Brazilian Real-World Multicentric Observational Study.
Chicago Style CitationFerreira, S., et al. Clinical Effectiveness and Safety of Vedolizumab Vs. Infliximab in Biologic-Naive Ulcerative Colitis Patients: A Brazilian Real-World Multicentric Observational Study. 2024.
MLA CitationFerreira, S., et al. Clinical Effectiveness and Safety of Vedolizumab Vs. Infliximab in Biologic-Naive Ulcerative Colitis Patients: A Brazilian Real-World Multicentric Observational Study. 2024.
Note: citation formatting may not correspond 100% to that defined by the respective standard, to manage citations it is recommended to use the software Zotero
, which allows the automatic upload of Oasisbr references.